Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) → HCID 25253067, compound

HRID 914172Notes

Reaction equation

HRID 914172 reaction equation
[CH:1]1([N:7]2[CH2:13][C:12]([CH2:15][CH3:16])([F:14])[C:11](=[O:17])[N:10]([CH3:18])[C:9]3[CH:19]=[N:20][C:21]([NH:23][C:24]4[CH:32]=[CH:31][C:27]([C:28](O)=[O:29])=[CH:26][C:25]=4[O:33][CH3:34])=[N:22][C:8]2=3)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.CN(C(ON1N=[N:50][C:45]2[CH:46]=C[CH:48]=[N:49][C:44]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.Cl.CN1CC(N)C1>>[CH:1]1([N:7]2[CH2:13][C:12]([CH2:15][CH3:16])([F:14])[C:11](=[O:17])[N:10]([CH3:18])[C:9]3[CH:19]=[N:20][C:21]([NH:23][C:24]4[CH:32]=[CH:31][C:27]([C:28]([NH:50][CH:45]5[CH2:44][N:49]([CH3:48])[CH2:46]5)=[O:29])=[CH:26][C:25]=4[O:33][CH3:34])=[N:22][C:8]2=3)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1

Participants

4

Reactant 3

HCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 670505831-Methylazetidin-3-amine xhydrochlorideHCID 67117835HCID 67117835, compound

Product 1

HCID 25253067HCID 25253067, compound

Procedure

The title compound was synthesized from 4-(9-cyclohexyl-7-ethyl-7-fluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[5,4-b][1,4]diazepin-2-ylamino)-3-methoxybenzoic acid as described in the General procedure for amide bond synthesis using HATU and 1-methylazetidin-3-amine hydrochloride. The final compound was purified by reverse phase HPLC and basified to give the free base. 1H NMR (400 MHz, DMSO-d6) δ ppm 0.71-0.95 (m, 1H) 0.89 (t, J=7.3 Hz, 3H) 1.07-1.92 (m, 12H) 2.29 (s, 3H) 3.03 (t, J=7.1 Hz, 2H) 3.26 (s, 3H) 3.51-3.76 (m, 1H) 3.58 (t, J=7.2 Hz, 2H) 3.76-3.87 (m, 1H) 3.95 (s, 3H) 4.44 (m, 1H) 7.49 (d, J=8.3 Hz, 1H) 7.52 (s, 1H) 7.78 (s, 1H) 8.11 (s, 1H) 8.33 (d, J=8.6 Hz, 1H) 8.63 (d, J=6.8 Hz, 1H). [M+H] calc'd for C28H38FN7O3, 540. found 540.

Workup

  1. customas described in the General procedure for amide bond synthesis
  2. customThe final compound was purified by reverse phase HPLC
  3. customto give the free base

Sources & evidence

ORD record
ord-fc054530eeb14db1a69759601ca6ba94
Source dataset
uspto-grants-2011_09
Patent number
US08026234B2

Reaction notes

Loading…